Activation of CXCL12-CXCR4 signalling induces conversion of immortalised embryonic kidney cells into cancer stem-like cells

References

• Kirk R. Tumour evolution: evidence points to the existence of cancer stem cells. Nat Rev Clin Oncol. 2012;9(10):552.
   PubMedGoogle Scholar
• Iseghohi SO. Cancer stem cells may contribute to the difficulty in treating cancer. Genes Dis. 2016;3(1):7–10.
   PubMed Web of Science ®Google Scholar
• Golebiewska A, Brons NH, Bjerkvig R, et al. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell. 2011;8(2):136–147.
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432(7015):396–401.
   PubMed Web of Science ®Google Scholar
• Nishi M, Sakai Y, Akutsu H, et al. Induction of cells with cancer stem cell properties from nontumorigenic human mammary epithelial cells by defined reprogramming factors. Oncogene. 2014;33(5):643–652.
   PubMed Web of Science ®Google Scholar
• Zhang DG, Jiang AG, Lu HY, et al. Isolation, cultivation and identification of human lung adenocarcinoma stem cells. Oncol Lett. 2015;9(1):47–54.
   PubMed Web of Science ®Google Scholar
• Plaks V, Kong N, Werb Z. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell. 2015;16(3):225–238.
   PubMed Web of Science ®Google Scholar
• Ho IAW, Shim WSN. Contribution of the microenvironmental niche to glioblastoma heterogeneity. Biomed Res Int. 2017;2017:9634172.
   PubMed Web of Science ®Google Scholar
• Wang X, Prager BC, Wu Q, et al. Reciprocal signaling between glioblastoma stem cells and differentiated tumor cells promotes malignant progression. Cell Stem Cell. 2018;22(4):514–528. e515.
   PubMed Web of Science ®Google Scholar
• Tam WL, Weinberg RA. The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med. 2013;19(11):1438–1449.
   PubMed Web of Science ®Google Scholar
• Ivanov M, Kals M, Kacevska M, et al. Ontogeny, distribution and potential roles of 5-hydroxymethylcytosine in human liver function. Genome Biol. 2013;14(8):R83.
   PubMed Web of Science ®Google Scholar
• Sun X, Cheng G, Hao M, et al. CXCL12/CXCR4/CXCR7 chemokine axis and cancer progression. Cancer Metastasis Rev. 2010;29(4):709–722.
   PubMed Web of Science ®Google Scholar
• Zhao M, Discipio RG, Wimmer AG, et al. Regulation of CXCR4-mediated nuclear translocation of extracellular signal-related kinases 1 and 2. Mol Pharmacol. 2006;69(1):66–75.
   PubMed Web of Science ®Google Scholar
• Barbieri F, Bajetto A, Porcile C, et al. CXC receptor and chemokine expression in human meningioma: SDF1/CXCR4 signaling activates ERK1/2 and stimulates meningioma cell proliferation. Ann N Y Acad Sci. 2006;1090:332–343.
   PubMed Web of Science ®Google Scholar
• Chen D, Xia YL, Zuo K, et al. Crosstalk between SDF-1/CXCR4 and SDF-1/CXCR7 in cardiac stem cell migration. Sci Rep. 2015;5:16813.
   PubMed Web of Science ®Google Scholar
• Peng SB, Peek V, Zhai Y, et al. Akt activation, but not extracellular signal-regulated kinase activation, is required for SDF-1alpha/CXCR4-mediated migration of epitheloid carcinoma cells. Mol Cancer Res. 2005; 3:227–236.
   PubMed Web of Science ®Google Scholar
• Liang Z, Brooks J, Willard M, et al. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway. Biochem Biophys Res Commun. 2007;359(3):716–722.
   PubMed Web of Science ®Google Scholar
• Huang C, Gu H, Zhang W, et al. SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury. Am J Physiol Heart Circ Physiol. 2011;301(4):H1496–1505.
   PubMed Web of Science ®Google Scholar
• Islam F, Gopalan V, Smith RA, et al. Translational potential of cancer stem cells: a review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment. Exp Cell Res. 2015;335(1):135–147.
   PubMed Web of Science ®Google Scholar
• Yu SC, Ping YF, Yi L, et al. Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87. Cancer Lett. 2008;265(1):124–134.
   PubMed Web of Science ®Google Scholar
• Jeon HM, Sohn YW, Oh SY, et al. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011;71(9):3410–3421.
   PubMed Web of Science ®Google Scholar
• Zou Q, Yan Q, Zhong J, et al. Direct conversion of human fibroblasts into neuronal restricted progenitors. J Biol Chem. 2014;289(8):5250–5260.
   PubMed Web of Science ®Google Scholar
• Debeb BG, Zhang X, Krishnamurthy S, et al. Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells. Mol Cancer. 2010;9:180.
   PubMed Web of Science ®Google Scholar
• Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555–567.
   PubMed Web of Science ®Google Scholar
• Huang EH, Singh B, Cristofanilli M, et al. A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. J Surg Res. 2009;155(2):231–236.
   PubMed Web of Science ®Google Scholar
• DeCastro AJ, Cherukuri P, Balboni A, et al. ΔNP63α transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis. Mol Cancer Ther. 2015;14(1):225–235.
   PubMed Web of Science ®Google Scholar
• Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell. 2014;14(3):275–291.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T. In vitro generation of human cells with cancer stem cell properties. Nat Cell Biol. 2011;13(9):1051–1061.
   PubMed Web of Science ®Google Scholar
• Calabrese C, Poppleton H, Kocak M, et al. A perivascular niche for brain tumor stem cells. Cancer Cell. 2007;11(1):69–82.
   PubMed Web of Science ®Google Scholar
• Melzer C, von der Ohe J, Lehnert H, et al. Cancer stem cell niche models and contribution by mesenchymal stroma/stem cells. Mol Cancer. 2017;16(1):28:
   PubMed Web of Science ®Google Scholar
• Farace C, Oliver JA, Melguizo C, et al. Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells. PLoS One. 2015;10(7):e0134111.
   PubMed Web of Science ®Google Scholar
• Liu YC, Lee IC, Chen PY. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype. J Neurooncol. 2018;137(3):511–522.
   PubMed Web of Science ®Google Scholar
• Zhou P, Li B, Liu F, et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer. Mol Cancer. 2017;16(1):52.
   PubMed Web of Science ®Google Scholar